Ikuti
Helen Heslop
Helen Heslop
Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital and Texas
Email yang diverifikasi di bcm.edu
Judul
Dikutip oleh
Dikutip oleh
Tahun
Hematology: basic principles and practice
R Hoffman, EJ Benz Jr, LE Silberstein, H Heslop, J Anastasi, J Weitz
Elsevier Health Sciences, 2013
16672013
Inducible apoptosis as a safety switch for adoptive cell therapy
A Di Stasi, SK Tey, G Dotti, Y Fujita, A Kennedy-Nasser, C Martinez, ...
New England Journal of Medicine 365 (18), 1673-1683, 2011
15732011
Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation
CM Rooney, CYC Ng, S Loftin, CA Smith, C Li, RA Krance, MK Brenner, ...
The Lancet 345 (8941), 9-13, 1995
13631995
Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus–induced lymphoma in allogeneic transplant recipients
CM Rooney, CA Smith, CYC Ng, SK Loftin, JW Sixbey, Y Gan, ...
Blood, The Journal of the American Society of Hematology 92 (5), 1549-1555, 1998
13561998
Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma
MA Pule, B Savoldo, GD Myers, C Rossig, HV Russell, G Dotti, MH Huls, ...
Nature medicine 14 (11), 1264-1270, 2008
13362008
Antitumor activity and long-term fate of chimeric antigen receptor–positive T cells in patients with neuroblastoma
CU Louis, B Savoldo, G Dotti, M Pule, E Yvon, GD Myers, C Rossig, ...
Blood, The Journal of the American Society of Hematology 118 (23), 6050-6056, 2011
12822011
CD28 costimulation improves expansion and persistence of chimeric antigen receptor–modified T cells in lymphoma patients
B Savoldo, CA Ramos, E Liu, MP Mims, MJ Keating, G Carrum, ...
The Journal of clinical investigation 121 (5), 1822-1826, 2011
12192011
Long–term restoration of immunity against Epstein–Barr virus infection by adoptive transfer of gene–modified virus–specific T lymphocytes
HE Heslop, CYC Ng, C Li, CA Smith, SK Loftin, RA Krance, MK Brenner, ...
Nature medicine 2 (5), 551-555, 1996
10161996
Human epidermal growth factor receptor 2 (HER2)–specific chimeric antigen receptor–modified T cells for the immunotherapy of HER2-positive sarcoma
N Ahmed, VS Brawley, M Hegde, C Robertson, A Ghazi, C Gerken, E Liu, ...
Journal of clinical oncology 33 (15), 1688, 2015
10002015
Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients
HE Heslop, KS Slobod, MA Pule, GA Hale, A Rousseau, CA Smith, ...
Blood, The Journal of the American Society of Hematology 115 (5), 925-935, 2010
8942010
An inducible caspase 9 safety switch for T-cell therapy
KC Straathof, MA Pule, P Yotnda, G Dotti, EF Vanin, MK Brenner, ...
Blood 105 (11), 4247-4254, 2005
7892005
Closely related T-memory stem cells correlate with in vivo expansion of CAR. CD19-T cells and are preserved by IL-7 and IL-15
Y Xu, M Zhang, CA Ramos, A Durett, E Liu, O Dakhova, H Liu, ...
Blood, The Journal of the American Society of Hematology 123 (24), 3750-3759, 2014
7172014
HER2-specific chimeric antigen receptor–modified virus-specific T cells for progressive glioblastoma: a phase 1 dose-escalation trial
N Ahmed, V Brawley, M Hegde, K Bielamowicz, M Kalra, D Landi, ...
JAMA oncology 3 (8), 1094-1101, 2017
6852017
Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals
AM Leen, GD Myers, U Sili, MH Huls, H Weiss, KS Leung, G Carrum, ...
Nature medicine 12 (10), 1160-1166, 2006
6312006
Engineering CD19-specific T lymphocytes with interleukin-15 and a suicide gene to enhance their anti-lymphoma/leukemia effects and safety
V Hoyos, B Savoldo, C Quintarelli, A Mahendravada, M Zhang, J Vera, ...
Leukemia 24 (6), 1160-1170, 2010
6022010
Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study
CRY Cruz, KP Micklethwaite, B Savoldo, CA Ramos, S Lam, S Ku, ...
Blood, The Journal of the American Society of Hematology 122 (17), 2965-2973, 2013
5802013
Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation
AM Leen, CM Bollard, AM Mendizabal, EJ Shpall, P Szabolcs, JH Antin, ...
Blood, The Journal of the American Society of Hematology 121 (26), 5113-5123, 2013
5802013
T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor model
A Di Stasi, B De Angelis, CM Rooney, L Zhang, A Mahendravada, ...
Blood, The Journal of the American Society of Hematology 113 (25), 6392-6402, 2009
5752009
A chimeric T cell antigen receptor that augments cytokine release and supports clonal expansion of primary human T cells
MA Pulè, KC Straathof, G Dotti, HE Heslop, CM Rooney, MK Brenner
Molecular Therapy 12 (5), 933-941, 2005
5682005
Post-transplant lymphoproliferative disorders
S Gottschalk, CM Rooney, HE Heslop
Annu. Rev. Med. 56, 29-44, 2005
5462005
Sistem tidak dapat melakukan operasi ini. Coba lagi nanti.
Artikel 1–20